The ISTH‐BAT score and outcomes after endometrial ablation in women with heavy menstrual bleeding

Author:

Eising Heleen P.12ORCID,Punt Marieke C.1,Schermer Tjard3,Leemans Jaklien C.4,Bongers Marlies Y.24

Affiliation:

1. Department of Gynaecology and Obstetrics Gelre Hospital Apeldoorn The Netherlands

2. Grow Research School Oncology and Reproduction Maastricht University Maastricht The Netherlands

3. Gelre Leerhuis, Department of Epidemiology Gelre Hospitals Apeldoorn The Netherlands

4. Department of Gynaecology and Obstetrics Máxima Medical Center Veldhoven The Netherlands

Abstract

AbstractBackgroundThe International Society on Thrombosis and Haemostasis bleeding assessment tool (ISTH‐BAT), is used during the diagnostic workup of bleeding disorders. Data on ISTH‐BAT scores in women with heavy menstrual bleeding (HMB) undergoing endometrial ablation (EA) could be essential in optimizing HMB counselling.ObjectiveTo investigate the postsurgical incidence of amenorrhea, dysmenorrhea, quality of life, re‐intervention after EA, and ISTH‐BAT score.MethodsThis study included women who have undergone EA because of HMB. During a follow‐up of 2 to 5 years, ISTH‐BAT, pictorial blood assessment chart (PBAC), and Short Form‐36 survey (SF‐36) were administered. At 10 years of follow‐up surgical re‐interventions were evaluated.ResultsSeventy‐one women were included of whom 77% (n = 55) had an ISTH‐BAT score < 6, versus 23% (n = 16) ISTH‐BAT score ≥6 (mean age 46.3 versus 42.3, p = 0.004). In the ISTH‐BAT ≥6 group versus < 6 group, amenorrhea occurred in 63% (10/16) versus 82% (45/55) (p = 0.111), dysmenorrhea in 38% (6/16) versus 18% (10/55) (p = 0.111), and surgical re‐intervention in 19% (3/16) versus 25% (14/55) (p = 0.582). SF‐36 item (Bodily) pain was lower in the ISTH‐BAT ≥6 group versus < 6 (median score 58.7 vs. 80.0, p = 0.104).ConclusionsAn ISTH‐BAT score ≥6 may be related to a lower amenorrhea incidence and higher dysmenorrhea rate after EA.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3